Pathways to Neuroprediction: Opportunities and Challenges to Prediction of Treatment Response in Depression
Pathways to Neuroprediction: Opportunities and Challenges to Prediction of Treatment Response in Depression
复制标题
DOI：
10.1007/s40473-018-0140-2
复制
发表时间：
2018-01
影响因子：
1.7
通讯作者：
S. Langenecker;Natania A. Crane;Lisanne M. Jenkins;K. Phan;H. Klumpp
中科院分区：
文献类型：
--
作者：
S. Langenecker;Natania A. Crane;Lisanne M. Jenkins;K. Phan;H. Klumpp
Purpose of ReviewWe set out to review the current state of science in neuroprediction, using biological measures of brain function, with task based fMRI to prospectively predict response to a variety of treatments.Recent FindingsTask-based fMRI neuroprediction studies are balanced between whole brain and ROI specific analyses. The predominant tasks are emotion processing, with ROIs based upon amygdala and subgenual anterior cingulate gyrus, both within the salience and emotion network. A rapidly emerging new area of neuroprediction is of disease course and illness recurrence. Concerns include use of open-label and single arm studies, lack of consideration of placebo effects, unbalanced adjustments for multiple comparisons (over focus on type I error), small sample sizes, unreported effect sizes, overreliance on ROI studies.SummaryThere is a need to adjust neuroprediction study reporting so that greater coherence can facilitate meta analyses, and increased funding for more multiarm studies in neuroprediction.
